supported by a grant from the National Natural Science Foundation of China(No.30470457)
Summary: Angiogenic gene therapy and cell-based therapy for peripheral arterial disease (PAD) have been studied intensively currently. This study aimed to investigate whether combining mesenchymal stem cells (MSCs...
目的研究血浆和斑块局部受激活后调节性正常T细胞表达和分泌因子(regulated on activated normal T cellexpressed and secreted factor,RANTES)表达水平与兔动脉粥样硬化斑块内血管平滑肌细胞(vascular smooth musclecells,VSMCs)凋亡...
This work was supported by grants from the National Natural Science Foundation of China (No. 30470457), Shanxi Province Natural Science Foundation (No. 2009011055-4), and Scientific Research Foundation of High Education Institutions of Shanxi Province, China (No. 200811034).
Background Tissue-engineered bioartificial muscle-based gene therapy represents a promising approach for the treatment of heart diseases. Experimental and clinical studies suggest that systemic administration of insul...
the National Natural Sciences Foundation of China (No. 30470457)
This study examined the change of p16^INK4a and PNCA protein expression in myocardium after injection of hIGF-1 gene modified skeletal myoblasts into post-infarction rats. HIGF-1 gene modified skeletal myoblasts (hIG...